Does Blood Flow Restriction Training Improve Quadriceps Function After Arthroscopic Knee Surgery?
Launched by THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER, HOUSTON · Mar 29, 2017
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether a special type of exercise called Blood Flow Restriction (BFR) training, when combined with regular physical therapy (PT), can help patients recover better after having surgery to repair their anterior cruciate ligament (ACL). The researchers want to see if this combined approach can help improve muscle strength and function in the quadriceps, which is the large muscle at the front of the thigh, and reduce muscle loss during recovery. They believe that using BFR training may lead to better outcomes for patients, especially those who are looking to return to sports after their surgery.
To participate in this study, you need to have had ACL reconstruction surgery, possibly along with other knee procedures like fixing a meniscus or cartilage. You should also be following specific guidelines about how much weight you can put on your leg during recovery. However, if you are pregnant, have certain medical conditions like cancer or deep vein thrombosis, or cannot attend physical therapy, you may not be eligible to join. If you do take part, you can expect to engage in physical therapy sessions that include BFR training and help track your recovery progress. This study is currently looking for participants of all genders, aged between 13 and 88.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Anterior cruciate ligament (ACL) reconstruction with concomitant meniscus or cartilage restoration procedures
- • Adherence to modified weight bearing status before initiation of PT
- • Expected participation in recreational or competitive sports after release to full activities
- Exclusion Criteria:
- • Unable to attend (or participate in) physical therapy
- • Pregnancy
- • Malignancy
- • Fracture
- • Peripheral vascular disease
- • History of deep vein thrombosis (DVT)
About The University Of Texas Health Science Center, Houston
The University of Texas Health Science Center at Houston (UTHealth) is a leading academic institution dedicated to advancing health through education, research, and clinical practice. As a prominent sponsor of clinical trials, UTHealth leverages its extensive resources and expertise in biomedical research to facilitate innovative studies aimed at improving patient outcomes. The institution is committed to fostering a collaborative environment that promotes scientific discovery and the translation of research findings into effective healthcare solutions, all while adhering to the highest ethical standards and regulatory guidelines. With a multidisciplinary approach, UTHealth plays a critical role in addressing complex health challenges and enhancing the quality of life in diverse communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Walter R Lowe, MD
Principal Investigator
The University of Texas Health Science Center, Houston
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials